Last $10.70 USD
Change Today +0.40 / 3.88%
Volume 1.0M
RPTP On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 2:16 PM 03/5/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for raptor pharmaceutical corp (RPTP)

Raptor Pharmaceuticals Corp. appears to have a strong balance sheet and has grown its cash reserves consistently over the last four years to total $149.6M USD. Accounts Receivable are among the industry's worst with 35.81 days worth of sales outstanding. This implies that revenues are not being collected in an efficient manner. Last, inventories seem to be well managed as the Inventory Processing Period is typical for the industry, at 235.18 days.
Currency in
Millions of US Dollars
As of:Aug 31
2011
Restated
Dec 31
2012
Restated
Dec 31
2013
Dec 31
2014
Press
Release
4 Year
Trend
Assets    
Cash and Equivalents15.236.383.1149.6
Short-Term Investments--22.1----
TOTAL CASH AND SHORT TERM INVESTMENTS15.258.483.1149.6
Accounts Receivable----6.27.5
TOTAL RECEIVABLES----6.27.5
Inventory----3.09.1
Prepaid Expenses0.41.63.63.8
Restricted Cash0.10.20.51.6
TOTAL CURRENT ASSETS15.760.296.3171.6
Gross Property Plant and Equipment0.61.02.5--
Accumulated Depreciation-0.5-0.6-0.7--
NET PROPERTY PLANT AND EQUIPMENT0.10.41.85.9
Goodwill3.33.33.33.3
Deferred Charges, Long Term----2.8--
Other Intangibles3.32.23.23.0
Other Long-Term Assets0.32.11.35.3
TOTAL ASSETS22.668.1108.7189.1
    
LIABILITIES & EQUITY    
Accounts Payable0.84.65.32.6
Accrued Expenses2.22.212.816.9
Current Portion of Long-Term Debt/Capital Lease0.00.00.09.0
Current Portion of Capital Lease Obligations0.00.00.0--
Other Current Liabilities, Total23.616.47.40.7
Unearned Revenue, Current----4.7--
TOTAL CURRENT LIABILITIES26.723.230.129.1
Long-Term Debt--25.050.0111.0
Capital Leases0.00.00.0--
TOTAL LIABILITIES26.748.280.2140.1
Common Stock0.00.10.10.1
Additional Paid in Capital73.8155.9234.3306.8
Retained Earnings-78.0-135.9-205.4-257.9
Comprehensive Income and Other0.0-0.1-0.4-0.1
TOTAL COMMON EQUITY-4.119.928.648.9
TOTAL EQUITY-4.119.928.648.9
TOTAL LIABILITIES AND EQUITY22.668.1108.7189.1
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RPTP:US $10.70 USD +0.40

RPTP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RPTP.
View Industry Companies
 

Industry Analysis

RPTP

Industry Average

Valuation RPTP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 9.0x
Price/Book 13.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 5.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RAPTOR PHARMACEUTICAL CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.